Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0T1MP
|
||||
| Former ID |
DIB004073
|
||||
| Drug Name |
Lurosetron
|
||||
| Synonyms |
Lurosetron mesylate; GR-87442; GR-87442N
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Emesis [ICD9: 787; ICD10:R11] | Discontinued in Phase 2 | [545348] | ||
| Company |
Glaxo Wellcome plc
|
||||
| Formula |
C17H17FN4O
|
||||
| Canonical SMILES |
c12c(n(c3c2cccc3F)C)CCN(C1=O)Cc1nc[nH]c1C
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | 5-Hydroxytryptamine 3 receptor | Target Info | Modulator | [550949] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.